Earnings · China A-shares
EVOPOINT BIOSCIENCES CO LTD (688837) earnings
EVOPOINT BIOSCIENCES CO LTD published its Q3 report on 2026-10-28: net profit -182.25% year on year, -179.05% excluding one-off items. Wave Radar's earnings-quality score is 59 of 100 (Questionable). The stock moved -6.84% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-28
- Period end
- 2026-09-30
- Net profit YoY
- -182.25%
- Excl. one-offs YoY
- -179.05%
- Result
- Bad / loss
- Quality score
- 59
- Quality
- Questionable
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -5.43% | — |
| 3 days | -6.84% | — |
| 7 days | +5.14% | — |
| 14 days | -9.56% | — |
Report history
Over the last 2 reports, net profit grew year on year in 1 of them.
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after |
|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-29 | -¥295.93M | -182.25% | — | -75.04% | -0.79 | -45.60% | -6.84% |
| 2026 interim report | 2026-08-26 | -¥167.78M | +55.11% | +25.34% | — | -0.45 | -27.08% | — |
The last 2 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.